AMENDMENT NO. 1 TO LICENSE OPTION AGREEMENTLicense Option Agreement • July 19th, 2016 • Immune Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Amendment No. 1 to the License Option Agreement (the "Agreement") made and entered into as of the 18th day of July 2016, between Immune Pharmaceuticals Inc., a Delaware corporation (“Immune”) and Novel Pain Therapeutics, LLC., a New York limited liability company (“NPT”), both referred to hereinafter referred to as the "Parties."
